Cécile Lambe
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Cécile Lambe has a total of 109 co-authors. Here are the top co-authors by number of shared publications:
Olivier Goulet
Department of Pediatric Gastroenterology, Necker Hospital, Paris-Cité University - AP-HP, Paris, France
8 shared publicationsCécile Talbotec
Department of Pediatric Gastroenterology, Necker Hospital, Paris-Cité University - AP-HP, Paris, France
4 shared publications- Olivier Goulet
Hôpital Necker-Enfants Malades, University Paris Cité Sorbonne Paris Descartes Medical School
3 shared publications - Bénédicte Pigneur
Service de Gastro‐entérologie et Nutrition pédiatrique, Centre de Référence Des Maladies Rares Digestives (MARDI), assistance Publique – Hôpitaux de Paris, Hôpital Necker Enfants Malades Université Paris Cité Paris France
2 shared publications Elie Abi Nader
Service de Gastro-entérologie et Nutrition pédiatrique, Université Paris Cité, Hôpital Necker-Enfants Malades, Paris
2 shared publications- Elie Abi Nader
Division of Pediatric Gastroenterology, Hepatology and Nutrition, Necker-Enfants Malades University of Paris-UFR Paris Descartes, Certified Center for Home Parenteral Nutrition, Reference Center for Rare Digestive Diseases in Children, Paris, France
2 shared publications
Latest Publications
- Open Access
- 3 November 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (6)
Long-term outcomes after total colonic aganglionosis: retrospective European multicentre cohort study
Background: Total colon aganglionosis (TCA), a severe form of Hirschsprung disease, is a rare and complex condition with variable management and limited outcome data. This retrospective cross-sectional multicentre study assessed current long-term outcomes of TCA in Europe. Methods: Patients with TCA under follow up at participating ERNICA and ESPGHAN centres were included. Data were collected on genetics, nutritional, functional, and surgical outcomes, intestinal inflammatory lesions, and mortality during the preceding 10 years. Results: Thirty-one centres from 15 countries contributed 401 patients (median age 7.9 years; interquartile range 4.0–13.6 years). Genetic testing was performed in 52% of patients, with pathogenic variants identified in 62%, mainly RET. Aganglionosis was limited to the colon in 26%, extended to the small bowel in 71%, and was total intestinal in 3%, without association with genetic status. At the latest follow-up, 25% of patients were receiving parenteral nutrition (PN); PN dependency was associated with small intestine extension of aganglionosis > 50 cm (72% of patients with >50 cm small bowel aganglionosis versus 15% of patients aganglionosis <50 cm small bowel or limited to the colon; P < 0.001). Overall, 77% of patients underwent pull-through, most commonly ileoanal anastomosis (62%) or Duhamel (31%). Complications included anastomotic leak (4%), strictures (12%), redo surgery (24%), recurrent enterocolitis (36%), obstructive symptoms (24%), and faecal incontinence (25%). Recurrent enterocolitis was associated with obstructive symptoms (P = 0.007). Endoscopy showed intestinal inflammatory lesions in 22% of patients, particularly those with recurrent enterocolitis (odds ratio (OR) 6.43; 95% confidence interval (c.i.) 3.27 to 12.63) and obstructive symptoms (OR 2.64; 95% c.i. 1.26 to 5.53). The 10-year mortality rate was 3.4%. Conclusion: TCA shows a high prevalence of genetic abnormalities and substantial postoperative and long-term morbidity, independent of surgical technique.
- 3 November 2026
- Published by Oxford University Press (OUP) in BJS Open
- Vol. 10 (6)
Open AccessLong-term outcomes after total colonic aganglionosis: retrospective European multicentre cohort study
Background: Total colon aganglionosis (TCA), a severe form of Hirschsprung disease, is a rare and complex condition with variable management and limited outcome data. This retrospective cross-sectional multicentre study assessed current long-term outcomes of TCA in Europe. Methods: Patients with TCA under follow up at participating ERNICA and ESPGHAN centres were included. Data were collected on genetics, nutritional, functional, and surgical outcomes, intestinal inflammatory lesions, and mortality during the preceding 10 years. Results: Thirty-one centres from 15 countries contributed 401 patients (median age 7.9 years; interquartile range 4.0–13.6 years). Genetic testing was performed in 52% of patients, with pathogenic variants identified in 62%, mainly RET. Aganglionosis was limited to the colon in 26%, extended to the small bowel in 71%, and was total intestinal in 3%, without association with genetic status. At the latest follow-up, 25% of patients were receiving parenteral nutrition (PN); PN dependency was associated with small intestine extension of aganglionosis > 50 cm (72% of patients with >50 cm small bowel aganglionosis versus 15% of patients aganglionosis <50 cm small bowel or limited to the colon; P < 0.001). Overall, 77% of patients underwent pull-through, most commonly ileoanal anastomosis (62%) or Duhamel (31%). Complications included anastomotic leak (4%), strictures (12%), redo surgery (24%), recurrent enterocolitis (36%), obstructive symptoms (24%), and faecal incontinence (25%). Recurrent enterocolitis was associated with obstructive symptoms (P = 0.007). Endoscopy showed intestinal inflammatory lesions in 22% of patients, particularly those with recurrent enterocolitis (odds ratio (OR) 6.43; 95% confidence interval (c.i.) 3.27 to 12.63) and obstructive symptoms (OR 2.64; 95% c.i. 1.26 to 5.53). The 10-year mortality rate was 3.4%. Conclusion: TCA shows a high prevalence of genetic abnormalities and substantial postoperative and long-term morbidity, independent of surgical technique.
- Open Access
- 2 March 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (10) , 2532-2544
Histogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction
INTRODUCTION: Chronic intestinal pseudo-obstruction (CIPO) is a rare, heterogeneous disorder associated with severe morbidity. Genetic variants and histopathological lesions have been described, but their combined evaluation has rarely been assessed in adult CIPO cohorts. This study aimed to evaluate the contribution of integrated genetic and histological analyses in adults with CIPO. METHODS: We conducted a retrospective observational study of adults with CIPO followed at a national tertiary referral center. Patients with CIPO underwent genomic profiling, including next-generation sequencing (NGS) panel, long-range polymerase chain reaction (PCR), whole-exome, and whole-genome sequencing. Centralized histological analysis of full-thickness bowel biopsies and resections was integrated with genomic data to assess their combined impact on disease outcomes. RESULTS: The cohort included 130 patients (75 females, 55 males, aged 19–74 years), followed for up to 64 years. Genetic and histological analyses characterized 82% of the patients (genetic diagnosis: n = 65/112, 58%; histological diagnosis: n = 73/96, 76%), allowing the classification of patients into 6 groups: monogenic myopathy (n = 42), mitochondriopathy (n = 19), unspecified myopathy (n = 26), autoimmune myopathy (n = 8), neuropathy (n = 9), and others (n = 26). Survival and postoperative outcomes differed across groups. In this cohort, patients with monogenic myopathy had the most favorable long-term survival (adjusted hazard ratio: 0.06, 95% CI: 0.01–0.42; P = 0.004) and higher rates of improvement after bowel resection compared with other patients. DISCUSSION: Integrated genetic and histological evaluation informed etiological classification in adults with CIPO and may aid clinical decision-making.
- 2 March 2026
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 121 (10) , 2532-2544
Open AccessHistogenetic Classification Predicts Outcomes in 130 Adults With Chronic Intestinal Pseudo-Obstruction
INTRODUCTION: Chronic intestinal pseudo-obstruction (CIPO) is a rare, heterogeneous disorder associated with severe morbidity. Genetic variants and histopathological lesions have been described, but their combined evaluation has rarely been assessed in adult CIPO cohorts. This study aimed to evaluate the contribution of integrated genetic and histological analyses in adults with CIPO. METHODS: We conducted a retrospective observational study of adults with CIPO followed at a national tertiary referral center. Patients with CIPO underwent genomic profiling, including next-generation sequencing (NGS) panel, long-range polymerase chain reaction (PCR), whole-exome, and whole-genome sequencing. Centralized histological analysis of full-thickness bowel biopsies and resections was integrated with genomic data to assess their combined impact on disease outcomes. RESULTS: The cohort included 130 patients (75 females, 55 males, aged 19–74 years), followed for up to 64 years. Genetic and histological analyses characterized 82% of the patients (genetic diagnosis: n = 65/112, 58%; histological diagnosis: n = 73/96, 76%), allowing the classification of patients into 6 groups: monogenic myopathy (n = 42), mitochondriopathy (n = 19), unspecified myopathy (n = 26), autoimmune myopathy (n = 8), neuropathy (n = 9), and others (n = 26). Survival and postoperative outcomes differed across groups. In this cohort, patients with monogenic myopathy had the most favorable long-term survival (adjusted hazard ratio: 0.06, 95% CI: 0.01–0.42; P = 0.004) and higher rates of improvement after bowel resection compared with other patients. DISCUSSION: Integrated genetic and histological evaluation informed etiological classification in adults with CIPO and may aid clinical decision-making.
- 20 November 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (3) , 602-605
Netherton syndrome: growth and endocrine assessment in a retrospective study of 37 paediatric patients
In this large retrospective cohort study of children with the syndromic epidermal differentiation disorder (sEDD) Netherton syndrome (now known as SPINK5-sEDD), we have further described the endocrine complications, as well as the frequency of growth hormone resistance, corticotropic insufficiency and rickets, thereby informing the need for systematic screening.
- 20 November 2025
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 194 (3) , 602-605
Netherton syndrome: growth and endocrine assessment in a retrospective study of 37 paediatric patients
In this large retrospective cohort study of children with the syndromic epidermal differentiation disorder (sEDD) Netherton syndrome (now known as SPINK5-sEDD), we have further described the endocrine complications, as well as the frequency of growth hormone resistance, corticotropic insufficiency and rickets, thereby informing the need for systematic screening.
- 4 October 2023
- Published by Springer Nature
- p. 313-335
Intestinal Failure in Childhood
- 3 May 2023
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 117 (6) , 1152-1163
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
- 3 May 2023
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 117 (6) , 1152-1163
Long-term treatment with teduglutide: a 48-week open-label single-center clinical trial in children with short bowel syndrome
- 1 February 2022
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 115 (2) , 422-431
Erythrocyte fatty acid membrane composition in children on long-term parenteral nutrition enriched with ω-3 fatty acids
Composite lipid emulsions containing soybean oil (30%), medium-chain triglycerides (30%), olive oil (25%), and fish oil (15%) (SMOF) are now widely used. We aimed to evaluate the tolerance, the efficiency, and the erythrocyte fatty acid (FA) profile for children on long-term home parenteral nutrition (HPN) receiving a composite fish oil-based emulsion (FOLE). At baseline, children (n = 46) with severe intestinal failure highly dependent on parenteral nutrition (PN) for ≥1 y were included in the study when they had received the composite FOLE for >6 mo. Out of this baseline group, only 25 children remained highly PN-dependent (SMOF1, n = 25) and could be assessed a second time, 2.4 y later (SMOF2, n = 25). An independent control group ("weaned off PN" group; n = 24) included children who had been weaned off PN for >2 y (median: 4 y). RBC-FA composition was established by GC-MS. Growth parameters, plasma citrulline, conjugated bilirubin, FA profiles, and the Holman ratio (20:3ω-9/20:4ω-6) were compared between groups. No difference for growth parameters, citrulline, and bilirubin was observed between the SMOF groups after 2.4 y (0.2 < P < 0.8). The weaned-off group did not differ from the SMOF groups for growth parameters (0.2 < P < 0.4) but citrulline was higher (P < 0.0001) and conjugated bilirubin lower (P < 0.01). The composite FOLE induced higher proportions of EPA (20:5n-3) (8.4% ± 2.9%) and DHA (22:6n-3) (11.7% ± 2.2%) than what was observed in weaned-off children (0.8% ± 0.4% and 6.6% ± 2.3%, respectively) but lower proportions of arachidonic acid (20:4n-6). However, the Holman ratio did not vary between groups (P = 0.9), whereas the PUFA concentrations varied widely. Long-term use of the composite FOLE was well tolerated in HPN-dependent children. The RBC-FA profile alterations were consistent with the ω-3 PUFA-enriched composition of this emulsion without evidence of essential FA deficiency.
- 1 February 2022
- Published by Elsevier in The American Journal of Clinical Nutrition
- Vol. 115 (2) , 422-431
Erythrocyte fatty acid membrane composition in children on long-term parenteral nutrition enriched with ω-3 fatty acids
Composite lipid emulsions containing soybean oil (30%), medium-chain triglycerides (30%), olive oil (25%), and fish oil (15%) (SMOF) are now widely used. We aimed to evaluate the tolerance, the efficiency, and the erythrocyte fatty acid (FA) profile for children on long-term home parenteral nutrition (HPN) receiving a composite fish oil-based emulsion (FOLE). At baseline, children (n = 46) with severe intestinal failure highly dependent on parenteral nutrition (PN) for ≥1 y were included in the study when they had received the composite FOLE for >6 mo. Out of this baseline group, only 25 children remained highly PN-dependent (SMOF1, n = 25) and could be assessed a second time, 2.4 y later (SMOF2, n = 25). An independent control group ("weaned off PN" group; n = 24) included children who had been weaned off PN for >2 y (median: 4 y). RBC-FA composition was established by GC-MS. Growth parameters, plasma citrulline, conjugated bilirubin, FA profiles, and the Holman ratio (20:3ω-9/20:4ω-6) were compared between groups. No difference for growth parameters, citrulline, and bilirubin was observed between the SMOF groups after 2.4 y (0.2 < P < 0.8). The weaned-off group did not differ from the SMOF groups for growth parameters (0.2 < P < 0.4) but citrulline was higher (P < 0.0001) and conjugated bilirubin lower (P < 0.01). The composite FOLE induced higher proportions of EPA (20:5n-3) (8.4% ± 2.9%) and DHA (22:6n-3) (11.7% ± 2.2%) than what was observed in weaned-off children (0.8% ± 0.4% and 6.6% ± 2.3%, respectively) but lower proportions of arachidonic acid (20:4n-6). However, the Holman ratio did not vary between groups (P = 0.9), whereas the PUFA concentrations varied widely. Long-term use of the composite FOLE was well tolerated in HPN-dependent children. The RBC-FA profile alterations were consistent with the ω-3 PUFA-enriched composition of this emulsion without evidence of essential FA deficiency.
- 1 October 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (10) , 5399-5406
The prevalence of feeding difficulties and potential risk factors in pediatric intestinal failure: Time to consider promoting oral feeds?
- 1 October 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (10) , 5399-5406
The prevalence of feeding difficulties and potential risk factors in pediatric intestinal failure: Time to consider promoting oral feeds?
- 1 October 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (10) , 5278-5287
Pediatric Home Parenteral Nutrition in France: A six years national survey
- 1 October 2021
- Published by Elsevier in Clinical Nutrition
- Vol. 40 (10) , 5278-5287
Pediatric Home Parenteral Nutrition in France: A six years national survey
- Open Access
- 1 October 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2802-2812
Beyond 10 years, with or without an intestinal graft: Present and future?
- 1 October 2020
- Published by Elsevier in American Journal of Transplantation
- Vol. 20 (10) , 2802-2812
Open AccessBeyond 10 years, with or without an intestinal graft: Present and future?